An Open Label Clinical Trial To Assess The Safety And Tolerability Of A Liquid Bovine Rotavirus Pentavalent Vaccine (LBRV-PV) Formulation In Healthy Adults
Phase of Trial: Phase I
Latest Information Update: 05 Mar 2018
At a glance
- Drugs Bovine rotavirus vaccine reassortant (Primary)
- Indications Rotavirus infections
- Focus Adverse reactions
- Sponsors Serum Institute of India
- 10 Feb 2018 Results assessing safety and tolerability of liquid bovine rotavirus pentavalent vaccine, published in the Vaccine.
- 06 Feb 2017 Status changed from recruiting to completed.
- 29 Aug 2016 New trial record